{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:23:38Z","timestamp":1750202618681},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T00:00:00Z","timestamp":1326153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00134-011-2453-4","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T16:47:37Z","timestamp":1326127657000},"page":"642-648","source":"Crossref","is-referenced-by-count":16,"title":["Standard subcutaneous dosing of unfractionated heparin for venous thromboembolism prophylaxis in surgical ICU patients leads to subtherapeutic factor Xa inhibition"],"prefix":"10.1007","volume":"38","author":[{"given":"Sara S.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Nordenholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Matero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Pearlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"McCarter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Gajdos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Hamiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Luzier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zung Vu","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Queensland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Wischmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"key":"2453_CR1","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","volume":"133","author":"WH Geerts","year":"2008","unstructured":"Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:381S\u2013453S","journal-title":"Chest"},{"key":"2453_CR2","doi-asserted-by":"crossref","first-page":"357S","DOI":"10.1378\/chest.124.6_suppl.357S","volume":"124","author":"W Geerts","year":"2003","unstructured":"Geerts W, Selby R (2003) Prevention of venous thromboembolism in the ICU. Chest 124:357S\u2013363S","journal-title":"Chest"},{"key":"2453_CR3","doi-asserted-by":"crossref","unstructured":"Leizorovicz A, Mismetti P (2004) Preventing venous thromboembolism in medical patients. Circulation 110:IV13\u2013IV19","DOI":"10.1161\/01.CIR.0000150640.98772.af"},{"key":"2453_CR4","doi-asserted-by":"crossref","unstructured":"Phung OJ, Kahn SR, Cook DJ, Murad MH (2011) Dosing frequency of unfractionated heparin thromboprophylaxis: a meta-analysis. Chest 140:374\u2013381","DOI":"10.1378\/chest.10-3084"},{"key":"2453_CR5","doi-asserted-by":"crossref","unstructured":"The PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group (2011) Dalteparin versus unfractionated heparin in critically Ill patients. N Engl J Med 364:1305\u20131314","DOI":"10.1056\/NEJMoa1014475"},{"key":"2453_CR6","doi-asserted-by":"crossref","first-page":"196135","DOI":"10.1155\/2011\/196135","volume":"2011","author":"A Zalpour","year":"2011","unstructured":"Zalpour A, Kroll MH, Afshar-Kharghan V, Yusuf SW, Escalante C (2011) Role of factor Xa inhibitors in cancer-associated thrombosis: any new data? Adv Hematol 2011:196135","journal-title":"Adv Hematol"},{"key":"2453_CR7","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/CCM.0b013e3181c9e344","volume":"38","author":"DJ Cook","year":"2010","unstructured":"Cook DJ, Crowther MA (2010) Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients. Crit Care Med 38:S76\u2013S82","journal-title":"Crit Care Med"},{"key":"2453_CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10354-011-0878-6","volume":"161","author":"D Fries","year":"2011","unstructured":"Fries D (2011) Thrombosis prophylaxis in critically ill patients. Wien Med Wochenschr 161:68\u201372","journal-title":"Wien Med Wochenschr"},{"key":"2453_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0049-3848(02)00028-2","volume":"105","author":"AJ Mayr","year":"2002","unstructured":"Mayr AJ, Dunser M, Jochberger S, Fries D, Klingler A, Joannidis M, Hasibeder W, Schobersberger W (2002) Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin. Thromb Res 105:201\u2013204","journal-title":"Thromb Res"},{"key":"2453_CR10","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/cc8924","volume":"14","author":"S Robinson","year":"2010","unstructured":"Robinson S, Zincuk A, Strom T, Larsen TB, Rasmussen B, Toft P (2010) Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care 14:R41","journal-title":"Crit Care"},{"key":"2453_CR11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0002-9378(95)91362-9","volume":"173","author":"LR Brancazio","year":"1995","unstructured":"Brancazio LR, Roperti KA, Stierer R, Laifer SA (1995) Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol 173:1240\u20131245","journal-title":"Am J Obstet Gynecol"},{"key":"2453_CR12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM197303152881103","volume":"288","author":"AS Gallus","year":"1973","unstructured":"Gallus AS, Hirsh J, Tutle RJ, Trebilcock R, O\u2019Brien SE, Carroll JJ, Minden JH, Hudecki SM (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288:545\u2013551","journal-title":"N Engl J Med"},{"key":"2453_CR13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1164\/ajrccm.161.4.9807025","volume":"161","author":"F Fraisse","year":"2000","unstructured":"Fraisse F, Holzapfel L, Couland JM, Simonneau G, Bedock B, Feissel M, Herbecq P, Pordes R, Poussel JF, Roux L (2000) Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The association of non-university affiliated intensive care specialist physicians of France. Am J Respir Crit Care Med 161:1109\u20131114","journal-title":"Am J Respir Crit Care Med"},{"key":"2453_CR14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00003246-198207000-00006","volume":"10","author":"JF Cade","year":"1982","unstructured":"Cade JF (1982) High risk of the critically ill for venous thromboembolism. Crit Care Med 10:448\u2013450","journal-title":"Crit Care Med"},{"key":"2453_CR15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa1014475","volume":"364","author":"D Cook","year":"2011","unstructured":"Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE, Zytaruk N, Crowther M, Geerts W, Cooper DJ, Vallance S, Qushmaq I, Rocha M, Berwanger O, Vlahakis NE (2011) Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 364:1305\u20131314","journal-title":"N Engl J Med"},{"key":"2453_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/bjs.1800720211","volume":"72","author":"D Bergqvist","year":"1985","unstructured":"Bergqvist D, Lindblad B (1985) A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 72:105\u2013108","journal-title":"Br J Surg"},{"key":"2453_CR17","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/cc4952","volume":"10","author":"MK Rommers","year":"2006","unstructured":"Rommers MK, Van der Lely N, Egberts TC, van den Bemt PM (2006) Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Crit Care 10:R93","journal-title":"Crit Care"},{"key":"2453_CR18","doi-asserted-by":"crossref","unstructured":"Zenahlikova Z, Kvasnicka J, Kudrnova Z, Sudrova M, Brzezkova R, Mazoch J, Malikova I, Vyborny J, Erhart D, Pecen L (2009) FXa inhibition and coagulation changes during DVT prophylaxis by enoxaparin over the course of a 15-day follow-up in septic patients. Clin Appl Thromb Hemost 16:584\u2013590","DOI":"10.1177\/1076029609345686"},{"key":"2453_CR19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(02)07920-5","volume":"359","author":"J Dorffler-Melly","year":"2002","unstructured":"Dorffler-Melly J, de Jonge E, Pont AC, Meijers J, Vroom MB, Buller HR, Levi M (2002) Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 359:849\u2013850","journal-title":"Lancet"},{"key":"2453_CR20","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1213\/ane.0b013e318168b367","volume":"106","author":"MT Ganter","year":"2008","unstructured":"Ganter MT, Hofer CK (2008) Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 106:1366\u20131375","journal-title":"Anesth Analg"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-011-2453-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-011-2453-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-011-2453-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T07:39:23Z","timestamp":1561189163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-011-2453-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["2453"],"URL":"https:\/\/doi.org\/10.1007\/s00134-011-2453-4","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,10]]}}}